Tìm theo
RP01
Thuốc Gốc
Small Molecule
RP01 is a novel anti-IgE immunotherapy for allergic individuals. It is designed to induce the immune system to produce antibodies that block Immunoglobulin E (IgE), the key mediator of an allergic response. It could offer benefit to millions of asthma and allergy patients.
Cơ Chế Tác Dụng : RP01 is a novel anti-IgE immunotherapy for allergic individuals. It is designed to induce the immune system to produce antibodies that block Immunoglobulin E (IgE), the key mediator of an allergic response. It could offer benefit to millions of asthma and allergy patients. RP01 is a novel immunotherapeutic that stimulates the immune system to produce antibodies against IgE (Immunoglobulin E), the key mediator of allergic reactions. The antibodies intercept and bind to IgE, thereby blocking it from causing allergic reactions. Such a mechanism of action is potentially effective regardless of the trigger, be it pollen, grass, dust mite, foodstuffs or pets.
Chỉ Định : Investigated for use/treatment in allergic reaction and asthma.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05751
... loading
... loading